 | This article has multiple issues. Please help improve it or discuss these issues on the talk page . (Learn how and when to remove these template messages)
|
Kristy Brock is a professor in the Department of Imaging Physics, Division of Diagnostic Imaging and is an adjunct professor in the Department of Radiation Physics, Division of Radiation Oncology at the University of Texas MD Anderson Cancer Center, Houston. [1]
Brock earned a B.S. in 1999, M.S. in 2000, and Ph.D. in 2003 in Nuclear Engineering and Radiological Sciences from the University of Michigan, Ann Arbor. [1]
Brock was an associate professor at the University Health Network in Toronto from 2003 to 2012. In 2012 she returned to her alma mater, the University of Michigan, as an associate and adjunct professor. Her positions were adjunct professor, Nuclear Engineering and Radiological Sciences, associate professor, Radiation Oncology, and associate professor, Biomedical Engineering. [2] She was in this position from 2012 to 2016. After four years there Brock transitioned to a tenured professor position at the MD Anderson Cancer Center in Houston.
Brock edited and wrote a book that was published in 2013 entitled Image Processing in Radiation Therapy. [3]
Medical physics deals with the application of the concepts and methods of physics to the prevention, diagnosis and treatment of human diseases with a specific goal of improving human health and well-being. Since 2008, medical physics has been included as a health profession according to International Standard Classification of Occupation of the International Labour Organization.
The University of Texas MD Anderson Cancer Center is a comprehensive cancer center in Houston, Texas. It is the largest cancer center in the world and one of the original three NCI-designated comprehensive cancer centers in the country. It is both a degree-granting academic institution and a cancer treatment and research center located within Texas Medical Center (TMC), Houston, the largest medical center and life sciences destination in the world. MD Anderson Cancer Center has consistently ranked #1 among the best hospitals for cancer care and research in the U.S. and worldwide, and it has held the #1 position 20 times in the last 23 years in U.S. News & World Report's Best Hospitals rankings for cancer care. As of 2023, MD Anderson Cancer Center is home to the highest number of cancer clinical trials in the world and has received more NCI-funded projects than any other U.S. institute. In 2024, Newsweek placed MD Anderson at #1 in their annual list of the World's Best Specialized Hospitals in oncology.
The Regional Cancer Centre (RCC) at Thiruvananthapuram is a cancer care hospital and research centre. RCC was established in 1981 by the Government of Kerala and the Government of India. It is located in the Thiruvananthapuram Medical College campus in Thiruvananthapuram, the capital city of the state of Kerala. It was established as an expansion of the Radiation Therapy / Radiotherapy department of Medical College Trivandrum. It is a tertiary care center for the managements of all types of cancers. The clinics are mainly on Haematology, Lymphoreticular, soft tissue, bone, head and neck, breast, CNS, gynaecological, urinary, chest, gastro, paediatric oncology and thyroid.
In radiotherapy, radiation treatment planning (RTP) is the process in which a team consisting of radiation oncologists, radiation therapist, medical physicists and medical dosimetrists plan the appropriate external beam radiotherapy or internal brachytherapy treatment technique for a patient with cancer.
Particle therapy is a form of external beam radiotherapy using beams of energetic neutrons, protons, or other heavier positive ions for cancer treatment. The most common type of particle therapy as of August 2021 is proton therapy.
Abass Alavi is an Iranian-American physician-scientist specializing in the field of molecular imaging, most notably in the imaging modality of positron emission tomography (PET). In August 1976, he was part of the team that performed the first human PET studies of the brain and whole body using the radiotracer [18F]Fluorodeoxyglucose (FDG). Alavi holds the position of Professor of Radiology and Neurology, as well as Director of Research Education in the Department of Radiology at the University of Pennsylvania. Over a career spanning five decades, he has amassed over 2,300 publications and 60,000 citations, earning an h-index of 125 and placing his publication record in the top percentile of scientists.
Bilikere Srinivasa Rao Dwarakanath is a molecular biologist and a radiation biologist, working on 2-Deoxy-D-glucose therapy in cancer research. His current research interests are experimental oncology, radiobiology, biological radioprotection and cell signaling in cancer therapy. He is currently the Joint Director of the Institute of Nuclear Medicine and Allied Sciences (INMAS), DRDO, Head, Division of Radiation Biosciences, INMAS, and Adjunct Faculty at the Dr. B. R. Ambedkar Center for Biomedical Research (ACBR), University of Delhi.
Carlos Alberto Pérez was an American radiation oncologist. He is well known for his contributions to the clinical management of patients, especially those with gynecologic tumors and carcinoma of the prostate, the breast and head and neck.
Henry Harrington Janeway was an American physician and pioneer of radiation therapy.
Ferenc Andras Jolesz was a Hungarian-American physician and scientist best known for his research on image guided therapy, the process by which information derived from diagnostic imaging is used to improve the localization and targeting of diseased tissue to monitor and control treatment during surgical and interventional procedures. He pioneered the field of Magnetic Resonance Imaging-guided interventions and introduced of a variety of new medical procedures based on novel combinations of imaging and therapy delivery.
Radhe Mohan is a medical physicist who significantly advanced radiation treatment safety for oncology patients. He is a recipient of the ASTRO Gold Medal for outstanding contributions in the field of radiation oncology.
Marco Durante is an Italian physicist, recognized as an expert in the fields of radiobiology and medical physics in charged particle therapy.
Eleanor D. Montague was an American radiologist and educator who established breast-conserving therapy in the United States and improved radiation therapy techniques. She became a member of the Texas Women's Hall of Fame in 1993.
Dr. Daniel Przybysz is a Brazilian Radiation-Oncologist. His practice is mainly focused on lung cancer treatment and high technology approaches toward better patient care
Jeffrey Harold Siewerdsen is an American physicist and biomedical engineer who is a Professor of Imaging Physics at The University of Texas MD Anderson Cancer Center as well as Biomedical Engineering, Computer Science, Radiology, and Neurosurgery at Johns Hopkins University.He is among the original inventors of cone-beam CT-guided radiotherapy as well as weight-bearing cone-beam CT for musculoskeletal radiology and orthopedic surgery. His work also includes the early development of flat-panel detectors on mobile C-arms for intraoperative cone-beam CT in image-guided surgery. He developed early models for the signal and noise performance of flat-panel detectors and later extended such analysis to dual-energy imaging and 3D imaging performance in cone-beam CT. He founded the ISTAR Lab in the Department of Biomedical Engineering, the Carnegie Center for Surgical Innovation at Johns Hopkins Hospital, and the Surgical Data Science Program at the Institute for Data Science in Oncology at The University of Texas MD Anderson Cancer Center.
Caridad Borrás is a Spanish medical physicist. Her career started in 1964 at the Santa Creu i Sant Pau Hospital in Barcelona. From 1988 to 2000, she was Regional Advisor of the Radiological Health Program and, from 2000 to 2002, Coordinator of Essential Drugs and Technology at the Pan American Health Organization in Washington D.C.
Julianne Pollard-Larkin is an American medical physicist, assistant professor at MD Anderson Cancer Center in Houston, TX and is also the interim Physics Service Chief for the Thoracic service of MD Anderson’s Division of Radiation Oncology. She is also the Vice-Chair of the American Association of Physicists in Medicine (AAPM) Diversity and Inclusion Subcommittee.
Anca-Ligia Grosu is a Romanian-German radiation oncologist and professor with a research focus on the development of personalized therapy in radiation oncology. She is chair of the Radiation Oncology Department at the University Medical Center Freiburg, Germany, and member of the German National Academy of Sciences Leopoldina.
Herman Day Suit was an American physician and radiation oncologist. Suit is a pioneer in precision radiotherapy and proton therapy for cancer.
Andre Dekker is a Dutch medical physicist, author, and academic who is a Professor and Head of Clinical Data Science at Maastricht University (UM), Maastricht UMC+ and Maastro Clinic. He also holds the position of Chief Scientific Officer at Medical Data Works.
